Results From a Phase II Trial of Reldesemtiv For Treating Spinal Muscular Atrophy Have Been Announced
rawpixel / Pixabay

Results From a Phase II Trial of Reldesemtiv For Treating Spinal Muscular Atrophy Have Been Announced

Data from a Phase II clinical trial of the experimental treatment reldesemtiv for the treatment of spinal muscular atrophy has been announced. The drug has shown positive effects in the…

Continue Reading Results From a Phase II Trial of Reldesemtiv For Treating Spinal Muscular Atrophy Have Been Announced
New Expanded Access Trials For FENIB and LOTS Patients Set to Begin
DarkoStojanovic / Pixabay

New Expanded Access Trials For FENIB and LOTS Patients Set to Begin

According to a story from globenewswire.com, the corporation Retrotope recently announced the initiation of single-patient, expanded access trials of its experimental product RT001. The patients involved have familial encephalopathy with neuroserpin…

Continue Reading New Expanded Access Trials For FENIB and LOTS Patients Set to Begin
Close Menu